| Ytd | -86.56% | |
| 1y | -83.34% |
| Open | 0.46 | Prev Close | 0.45 | Low | 0.46 | High | 0.48 | Mkt Cap | 24.65M |
| Vol | 90.43K | Avg Vol | 839.59K | EPS | -0.38 | P/E | -1.26 | Forward P/E | -3.81 |
| Beta | 1.42 | Short Ratio | 0.22 | Inst. Own | 48.66% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 0.49 | 200-d Avg | 2.45 | 1yr Est | 6.04 |
Company to Host Conference Call with Live Q&A, August 13, 2026, at 4:30pm ET / 22:30 CET IRVINE, Cal
Mdxhealth SA (NASDAQ:MDXH) (the "Company" or "mdxhealth"), a leader in urology-focus
Mdxhealth Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Listed Securiti
IRVINE, California – July 2, 2026 (GlobeNewswire) – Mdxhealth SA (NASDAQ: MDXH) (the "Company" or "m
Mdxhealth Announces Peer-Reviewed Publication of Oxford GPS-ProMPT Study in European Urology Oncolog
Analyst ratings for top names changed: Doximity cut to neutral, National Vision lowered price target
Cisco Inc (NASDAQ: CSCO) beat expectations and raised guidance with $15.84B revenue and $1.06 EPS. S
MDxHealth NASDAQ: MDXH reported first-quarter 2026 revenue of $27.4 million while announcing a strat
MDxHealth SA (MDXH) Q1 2026 Earnings Call Transcript
Mdxhealth Reports Q1-2026 Results Conference call with Q&A today at 4:30 PM ET / 22:30 CET IRVINE, C
Mdxhealth SA (NASDAQ: MDXH), a leading precision diagnostics company, today announced it will releas
MDxHealth SA (NASDAQ: MDXH - Get Free Report) has earned a consensus rating of "Moderate Buy" from t
MDxHealth (NASDAQ: MDXH - Get Free Report) and Health Catalyst (NASDAQ: HCAT - Get Free Report) are
Mdxhealth Highlights Data from Oxford's ProMPT Study Demonstrating the Genomic Prostate Score GPS Te
MDxHealth SA (MDXH) Q4 2025 Earnings Call Transcript
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on Feb
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidan
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment eff
Shares of MDxHealth SA (NASDAQ: MDXH - Get Free Report) have been assigned an average rating of "Mod
Shares of MDxHealth SA (NASDAQ: MDXH - Get Free Report) have received a consensus rating of "Moderat
MDxHealth SA ( MDXH ) Q3 2025 Earnings Call November 12, 2025 4:30 PM EST Company Participants Micha
If you are looking for stocks that are well positioned to maintain their recent uptrend, MDxHealth S
Appointment of Executive Chairman, proposed change of name and strategy update Company to pursue rev
Companies Reporting Before The Bell • CTS (NYSE:CTS) is estimated to report quarterly earnings at $
Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its
On Tuesday, 647 companies set new 52-week lows.